Market revenue in 2023 | USD 51.9 million |
Market revenue in 2030 | USD 67.2 million |
Growth rate | 3.8% (CAGR from 2023 to 2030) |
Largest segment | Malignant tumors |
Fastest growing segment | Functional Disorders |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Malignant Tumors, Benign Tumors, Vascular Disorders, Functional Disorders, Ocular Diseases |
Key market players worldwide | Elekta AB ADR, Varian, Akesis Pharmaceuticals, Huiheng Industry |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gamma knife market will help companies and investors design strategic landscapes.
Malignant tumors was the largest segment with a revenue share of 44.51% in 2023. Horizon Databook has segmented the Japan gamma knife market based on malignant tumors, benign tumors, vascular disorders, functional disorders, ocular diseases covering the revenue growth of each sub-segment from 2018 to 2030.
Japan has the highest penetration of Leksell Gamma Knife systems, with 25% to 30% of the target population gaining access to this treatment. Presence of a large geriatric population, increase in burden of neurological diseases, and high expenditure of GDP on healthcare are among the key factors likely to boost the market.
Increase in adoption of advanced technologies is expected to further drive the market. Japan spends nearly 10.5% of its GDP on healthcare, enhancing the adoption of advanced oncology treatments. In November 2016, the first patient with brain metastasis was treated using Gamma Knife Icon.
Furukawa Seiryo Hospital, Yokohama Rosai Hospital, Atami Tokoro Memorial Hospital, and Nippon Steel Yawata Memorial Hospital are among the leading healthcare centers providing gamma knife radiotherapy in Japan.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan gamma knife market , including forecasts for subscribers. This country databook contains high-level insights into Japan gamma knife market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account